Literature DB >> 19802731

Inflammatory bowel disease: review from the aspect of genetics.

Shunji Ishihara1, M M Aziz, Takafumi Yuki, Hideaki Kazumori, Yoshikazu Kinoshita.   

Abstract

Regardless of how inflammatory bowel disease (IBD) is defined, the term "genetic susceptibility" is always included. Due to substantial progress in the characterization of susceptible genes that interact with environmental influences, a number of review articles offering the latest insights continue to be presented. To date, more than 30 novel IBD susceptible loci have been found, while several promising associations between IBD and gene variants have also been identified and replicated effectively. The present review highlights recent insights regarding linkage analysis and genome-wide association presented in studies of IBD susceptible genes, which provide additional evidence supporting their involvement in disease pathogenesis, based on linking to innate immune systems as a result of interactions with intestinal microbial flora. An improved understanding of IBD genetics will promote the identification of novel therapeutic agents, making it possible to identify environmental factors related to intestinal inflammation.

Entities:  

Mesh:

Year:  2009        PMID: 19802731     DOI: 10.1007/s00535-009-0141-8

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  126 in total

1.  Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease.

Authors:  Keiko Yamazaki; Dermot McGovern; Jiannis Ragoussis; Marta Paolucci; Helen Butler; Derek Jewell; Lon Cardon; Masakazu Takazoe; Torao Tanaka; Toshiki Ichimori; Susumu Saito; Akihiro Sekine; Aritoshi Iida; Atsushi Takahashi; Tatsuhiko Tsunoda; Mark Lathrop; Yusuke Nakamura
Journal:  Hum Mol Genet       Date:  2005-10-12       Impact factor: 6.150

Review 2.  Toll-like receptors: linking innate and adaptive immunity.

Authors:  Chandrashekhar Pasare; Ruslan Medzhitov
Journal:  Adv Exp Med Biol       Date:  2005       Impact factor: 2.622

3.  Human IRGM induces autophagy to eliminate intracellular mycobacteria.

Authors:  Sudha B Singh; Alexander S Davis; Gregory A Taylor; Vojo Deretic
Journal:  Science       Date:  2006-08-03       Impact factor: 47.728

4.  Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease.

Authors:  Jan Wehkamp; Klaus Fellermann; Klaus R Herrlinger; Steffi Baxmann; Klaus Schmidt; Bettina Schwind; Michael Duchrow; Charlotte Wohlschläger; Alfred C Feller; Eduard F Stange
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-07       Impact factor: 2.566

5.  Epithelial NEMO links innate immunity to chronic intestinal inflammation.

Authors:  Arianna Nenci; Christoph Becker; Andy Wullaert; Ralph Gareus; Geert van Loo; Silvio Danese; Marion Huth; Alexei Nikolaev; Clemens Neufert; Blair Madison; Deborah Gumucio; Markus F Neurath; Manolis Pasparakis
Journal:  Nature       Date:  2007-03-14       Impact factor: 49.962

6.  Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease.

Authors:  Giuseppe Mancuso; Angelina Midiri; Concetta Beninati; Carmelo Biondo; Roberta Galbo; Shizuo Akira; Philipp Henneke; Douglas Golenbock; Giuseppe Teti
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

7.  Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease.

Authors:  M F Neurath; I Fuss; G Schürmann; S Pettersson; K Arnold; H Müller-Lobeck; W Strober; C Herfarth; K H Büschenfelde
Journal:  Ann N Y Acad Sci       Date:  1998-11-17       Impact factor: 5.691

8.  Suppressor of cytokine signaling-1 regulates inflammatory bowel disease in which both IFNgamma and IL-4 are involved.

Authors:  Takatoshi Chinen; Takashi Kobayashi; Hisanobu Ogata; Giichi Takaesu; Hiromi Takaki; Masayuki Hashimoto; Hideo Yagita; Hajime Nawata; Akihiko Yoshimura
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

Review 9.  Immune responses of TLR5(+) lamina propria dendritic cells in enterobacterial infection.

Authors:  Satoshi Uematsu; Shizuo Akira
Journal:  J Gastroenterol       Date:  2009-06-24       Impact factor: 7.527

10.  Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease.

Authors:  Subra Kugathasan; Robert N Baldassano; Jonathan P Bradfield; Patrick M A Sleiman; Marcin Imielinski; Stephen L Guthery; Salvatore Cucchiara; Cecilia E Kim; Edward C Frackelton; Kiran Annaiah; Joseph T Glessner; Erin Santa; Tara Willson; Andrew W Eckert; Erin Bonkowski; Julie L Shaner; Ryan M Smith; F George Otieno; Nicholas Peterson; Debra J Abrams; Rosetta M Chiavacci; Robert Grundmeier; Petar Mamula; Gitit Tomer; David A Piccoli; Dimitri S Monos; Vito Annese; Lee A Denson; Struan F A Grant; Hakon Hakonarson
Journal:  Nat Genet       Date:  2008-08-31       Impact factor: 38.330

View more
  17 in total

1.  Down-regulation of single immunoglobulin interleukin-1R-related molecule (SIGIRR)/TIR8 expression in intestinal epithelial cells during inflammation.

Authors:  C Kadota; S Ishihara; M M Aziz; M A Rumi; N Oshima; Y Mishima; I Moriyama; T Yuki; Y Amano; Y Kinoshita
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

Review 2.  The role of B-1 cells in inflammation.

Authors:  Monowar Aziz; Nichol E Holodick; Thomas L Rothstein; Ping Wang
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

3.  Genetics of inflammatory bowel disease in Japan.

Authors:  Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2010-03-02       Impact factor: 7.527

Review 4.  Inflammatory bowel disease in the dog: differences and similarities with humans.

Authors:  Matteo Cerquetella; Andrea Spaterna; Fulvio Laus; Beniamino Tesei; Giacomo Rossi; Elisabetta Antonelli; Vincenzo Villanacci; Gabrio Bassotti
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

5.  Decreased production of interleukin-10 and transforming growth factor-β in Toll-like receptor-activated intestinal B cells in SAMP1/Yit mice.

Authors:  Yoshiyuki Mishima; Shunji Ishihara; Md Monowar Aziz; Akihiko Oka; Ryusaku Kusunoki; Aya Otani; Yasumasa Tada; Yong-Yu Li; Ichiro Moriyama; Naoki Oshima; Takafumi Yuki; Yuji Amano; Satoshi Matsumoto; Yoshikazu Kinoshita
Journal:  Immunology       Date:  2010-12       Impact factor: 7.397

6.  Inflammatory bowel disease in pediatric and adolescent patients: a biomolecular and histopathological review.

Authors:  Luciana Rigoli; Rosario Alberto Caruso
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

7.  Sirolimus ameliorates inflammatory responses by switching the regulatory T/T helper type 17 profile in murine colitis.

Authors:  Hui Yin; Xiangyong Li; Bobin Zhang; Tao Liu; Baohong Yuan; Qian Ni; Shilian Hu; Hongbiao Gu
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

8.  Eosinophil associated genes in the inflammatory bowel disease 4 region: correlation to inflammatory bowel disease revealed.

Authors:  Kristin Blom; Jenny Rubin; Jonas Halfvarson; Leif Törkvist; Anders Rönnblom; Per Sangfelt; Mikael Lördal; Ulla-Britt Jönsson; Urban Sjöqvist; Lena Douhan Håkansson; Per Venge; Marie Carlson
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

9.  Carbohydrate Elimination or Adaptation Diet for Symptoms of Intestinal Discomfort in IBD: Rationales for "Gibsons' Conundrum".

Authors:  Q Manyan Fung; Andrew Szilagyi
Journal:  Int J Inflam       Date:  2012-02-29

Review 10.  An overview of lipid abnormalities in patients with inflammatory bowel disease.

Authors:  Aris P Agouridis; Moses Elisaf; Haralampos J Milionis
Journal:  Ann Gastroenterol       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.